A detailed history of Janus Henderson Group PLC transactions in Illumina, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 3,684,585 shares of ILMN stock, worth $385 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
3,684,585
Previous 4,402,380 16.3%
Holding current value
$385 Million
Previous $613 Million 17.46%
% of portfolio
0.28%
Previous 0.38%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$127.73 - $147.2 $91.7 Million - $106 Million
-717,795 Reduced 16.3%
3,684,585 $506 Million
Q4 2023

Feb 14, 2024

SELL
$92.79 - $142.53 $32.1 Million - $49.2 Million
-345,529 Reduced 7.28%
4,402,380 $613 Million
Q3 2023

Nov 14, 2023

SELL
$128.91 - $192.44 $4.62 Million - $6.9 Million
-35,865 Reduced 0.75%
4,747,909 $652 Million
Q2 2023

Aug 14, 2023

BUY
$183.43 - $232.67 $262 Million - $333 Million
1,429,556 Added 42.62%
4,783,774 $897 Million
Q1 2023

May 15, 2023

BUY
$193.75 - $232.55 $332 Million - $398 Million
1,711,163 Added 104.15%
3,354,218 $780 Million
Q4 2022

Feb 14, 2023

SELL
$187.24 - $242.74 $24.5 Million - $31.8 Million
-130,934 Reduced 7.38%
1,643,055 $332 Million
Q3 2022

Nov 14, 2022

BUY
$177.23 - $227.44 $32.1 Million - $41.2 Million
181,237 Added 11.38%
1,773,989 $338 Million
Q2 2022

Aug 15, 2022

BUY
$181.58 - $368.0 $22.6 Million - $45.8 Million
124,551 Added 8.48%
1,592,752 $294 Million
Q1 2022

May 16, 2022

SELL
$303.87 - $423.8 $23.5 Million - $32.7 Million
-77,257 Reduced 5.0%
1,468,201 $513 Million
Q4 2021

Feb 14, 2022

SELL
$347.28 - $421.83 $5.59 Million - $6.79 Million
-16,108 Reduced 1.03%
1,545,458 $588 Million
Q3 2021

Nov 16, 2021

SELL
$405.61 - $524.84 $67.2 Million - $87 Million
-165,716 Reduced 9.59%
1,561,566 $633 Million
Q2 2021

Aug 16, 2021

SELL
$372.84 - $481.5 $372 Million - $481 Million
-998,701 Reduced 36.64%
1,727,282 $817 Million
Q1 2021

May 17, 2021

SELL
$361.28 - $504.76 $4.51 Million - $6.3 Million
-12,482 Reduced 0.46%
2,725,983 $1.05 Billion
Q4 2020

Feb 16, 2021

BUY
$292.7 - $370.96 $616 Million - $781 Million
2,105,636 Added 332.73%
2,738,465 $1.01 Billion
Q3 2020

Nov 16, 2020

BUY
$268.51 - $400.74 $91.3 Million - $136 Million
339,966 Added 116.08%
632,829 $196 Million
Q2 2020

Aug 14, 2020

SELL
$256.46 - $373.01 $21.6 Million - $31.4 Million
-84,147 Reduced 22.32%
292,863 $108 Million
Q1 2020

May 14, 2020

BUY
$209.2 - $335.53 $56.4 Million - $90.4 Million
269,464 Added 250.56%
377,010 $103 Million
Q4 2019

Feb 18, 2020

SELL
$288.29 - $335.49 $22 Million - $25.6 Million
-76,262 Reduced 41.49%
107,546 $35.7 Million
Q3 2019

Nov 14, 2019

SELL
$266.84 - $378.23 $9.02 Million - $12.8 Million
-33,788 Reduced 15.53%
183,808 $55.9 Million
Q2 2019

Jul 31, 2019

SELL
$300.59 - $368.15 $51.8 Million - $63.4 Million
-172,276 Reduced 44.19%
217,596 $80.1 Million
Q1 2019

Apr 30, 2019

BUY
$272.57 - $321.18 $25.7 Million - $30.3 Million
94,384 Added 31.94%
389,872 $121 Million
Q4 2018

Feb 06, 2019

BUY
$272.46 - $366.54 $38.7 Million - $52 Million
141,979 Added 92.49%
295,488 $88.6 Million
Q3 2018

Nov 09, 2018

SELL
$279.04 - $367.06 $7.73 Million - $10.2 Million
-27,686 Reduced 15.28%
153,509 $56.3 Million
Q2 2018

Aug 10, 2018

SELL
$228.17 - $292.07 $19 Million - $24.3 Million
-83,221 Reduced 31.47%
181,195 $50.6 Million
Q1 2018

May 14, 2018

SELL
$209.54 - $253.91 $13.2 Million - $16 Million
-63,126 Reduced 19.27%
264,416 $62.5 Million
Q4 2017

Feb 09, 2018

SELL
$202.23 - $230.03 $8.49 Million - $9.65 Million
-41,958 Reduced 11.36%
327,542 $71.6 Million
Q3 2017

Nov 14, 2017

BUY
$172.3 - $213.93 $6.8 Million - $8.45 Million
39,490 Added 11.97%
369,500 $0
Q2 2017

Aug 17, 2017

BUY
N/A
330,010
330,010 $57.3 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $16.4B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.